112 related articles for article (PubMed ID: 9578507)
21. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
22. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
[TBL] [Abstract][Full Text] [Related]
23. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy.
Stouthart PJ; Deijen JB; Roffel M; Delemarre-van de Waal HA
Psychoneuroendocrinology; 2003 Jul; 28(5):612-26. PubMed ID: 12727130
[TBL] [Abstract][Full Text] [Related]
24. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
[TBL] [Abstract][Full Text] [Related]
25. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study.
Soliman AT; abdul Khadir MM
J Trop Pediatr; 1996 Oct; 42(5):281-6. PubMed ID: 8936959
[TBL] [Abstract][Full Text] [Related]
26. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
[TBL] [Abstract][Full Text] [Related]
30. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
[TBL] [Abstract][Full Text] [Related]
31. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
Smyczynska J; Hilczer M; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
33. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
[TBL] [Abstract][Full Text] [Related]
34. Treatment of peripubertal children after renal transplantation (RTX) with recombinant human growth hormone: auxological data and effects on insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) during 24 months.
Riedl S; Lebl J; Kluge M; Kreisinger J; Simková E; Kohlhauser C; Balzar E; Frisch H
J Pediatr Endocrinol Metab; 1998; 11(6):713-8. PubMed ID: 9829225
[TBL] [Abstract][Full Text] [Related]
35. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
36. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
Soliman AT; El Banna N; Ansari BM
Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
[TBL] [Abstract][Full Text] [Related]
37. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
[TBL] [Abstract][Full Text] [Related]
38. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study.
Argüelles B; Barrios V; Pozo J; Muñoz MT; Argente J
J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437
[TBL] [Abstract][Full Text] [Related]
39. Predictors of growth response to growth hormone in otherwise normal short children.
Zadik Z; Landau H; Limoni Y; Lieberman E
J Pediatr; 1992 Jul; 121(1):44-8. PubMed ID: 1625091
[TBL] [Abstract][Full Text] [Related]
40. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
